Jiang Qian-Zhu, Xu Qian, Wan Dong-Mei, Kong Ying
Heilongjiang University of Chinese Medicine Harbin 150001, Heilongjiang, China.
First Ward of Cardiovascular Department, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine Harbin 150001, Heilongjiang, China.
Am J Transl Res. 2025 Apr 15;17(4):2352-2375. doi: 10.62347/FPXH3010. eCollection 2025.
To systematically analyze the factors associated with heart failure (HF) development after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS).
Relevant literature on risk factors for HF following PCI in ACS patients were retrieved from PubMed, Embase, The Cochrane Library, Web of Science, and Medline buildup to September 2024. Two independent investigators conducted literature screening, quality assessment, and data extraction based on inclusion and exclusion criteria. Meta-analysis was performed using Stata 12.0 software.
A total of 20 papers were included, comprising 45,578 patients of whom 4,345 ACS patients developed HF after PCI. Meta-analysis identified several predictors of post-PCI HF in ACS patients, including advanced age [odds ratio (OR) =1.04, 95% confidence intervals (CI): 1.03-1.06], female gender (OR=1.43, 95% CI: 1.18-1.72), history of hypertension (OR=1.54, 95% CI: 1.31-1.80), history of diabetes mellitus (OR=1.55, 95% CI: 1.39-1.72), previous myocardial infarction (OR=1.58, 95% CI: 1.11-2.23), anterior wall myocardial infarction (OR=2.22, 95% CI: 1.89-2.61), reduced left ventricular ejection fraction (LVEF) (OR=1.40, 95% CI: 1.21-1.62), elevated white blood cell count (OR=1.14, 95% CI: 1.07-1.22), atrial fibrillation [hazard ratio (HR) =2.14, 95% CI: 1.11-4.12], increased heart rate (OR=1.03, 95% CI: 1.02-1.04), elevated Pentraxin-3 (PTX3) levels (OR=2.67, 95% CI: 1.45-4.93), and decreased myocardial contractility (HR=1.18, 95% CI: 1.10-1.26). Notably, complete revascularization (HR=0.29, 95% CI: 0.10-0.86) was identified as a protective factor. Sensitivity analysis confirmed the robustness of these findings.
Advanced age, female gender, history of hypertension and diabetes, previous myocardial infarction, anterior wall myocardial infarction, decreased LVEF at admission, increased white blood cell count, atrial fibrillation at admission, increased heart rate, elevated PTX3 levels, and impaired myocardial contractility were risk factors for HF development after PCI in ACS patients. Conversely, complete revascularization was associated with a lower risk of post-PCI HF.
系统分析急性冠状动脉综合征(ACS)患者经皮冠状动脉介入治疗(PCI)后发生心力衰竭(HF)的相关因素。
检索截至2024年9月PubMed、Embase、Cochrane图书馆、Web of Science和Medline数据库中关于ACS患者PCI后发生HF危险因素的相关文献。两名独立研究人员根据纳入和排除标准进行文献筛选、质量评估和数据提取。使用Stata 12.0软件进行荟萃分析。
共纳入20篇论文,涉及45578例患者,其中4345例ACS患者在PCI后发生HF。荟萃分析确定了ACS患者PCI后发生HF的几个预测因素,包括高龄[比值比(OR)=1.04,95%置信区间(CI):1.03 - 1.06]、女性(OR = 1.43,95% CI:1.18 - 1.72)、高血压病史(OR = 1.54,95% CI:1.31 - 1.80)、糖尿病病史(OR = 1.55,95% CI:1.39 - 1.72)、既往心肌梗死(OR = 1.58,95% CI:1.11 - 2.23)、前壁心肌梗死(OR = 2.22,95% CI:1.89 - 2.61)、左心室射血分数(LVEF)降低(OR = 1.40,95% CI:1.21 - 1.62)、白细胞计数升高(OR = 1.14,95% CI:1.07 - 1.22)、心房颤动[风险比(HR) = 2.14,95% CI:1.11 - 4.12]、心率加快(OR = 1.03,95% CI:1.02 - 1.04)、五聚体3(PTX3)水平升高(OR = 2.67,95% CI:1.45 - 4.93)以及心肌收缩力下降(HR = 1.18,95% CI:1.10 - 1.26)。值得注意的是,完全血运重建(HR = 0.29,95% CI:0.10 - 0.86)被确定为保护因素。敏感性分析证实了这些结果的稳健性。
高龄、女性、高血压和糖尿病病史、既往心肌梗死、前壁心肌梗死、入院时LVEF降低、白细胞计数升高、入院时心房颤动、心率加快、PTX3水平升高以及心肌收缩力受损是ACS患者PCI后发生HF的危险因素。相反,完全血运重建与PCI后发生HF的风险较低相关。